PMID: 19929834Nov 26, 2009Paper

Start small and stay small. Minimizing attrition in the clinic with a focus on CNS therapeutics

Current Topics in Medicinal Chemistry
Vicki Nienaber

Abstract

Diseases of the central nervous system are among the most devastating to patients and their families. Despite this, treatments for these diseases have lagged behind other therapeutic areas. Although social and economic factors may be partly responsible for the paucity of therapeutic agents, a particularly daunting challenge for CNS drug discovery is the need for compounds to cross the blood brain barrier. Recent analyses of successful drugs have shown that their chemical properties have not changed substantially over the past 40 years while the properties of compounds entering the clinic have become inflated. This property inflation has only exacerbated the challenges of CNS drug discovery as the requirements for delivery to the brain are even more stringent than those for other tissues. New approaches are needed to meet these challenges. In this review, we discuss the merits of fragment based lead discovery and how it may be used to address the challenges of CNS drug discovery. We also summarize compounds discovered by high-throughput screening, substrate evolution and fragment-based lead discovery for well known CNS targets. The results indicate that FBLD may be a key method for discovery of brain penetrable CNS therapeutics.

Citations

Dec 14, 2011·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Inge van RooyEnrico Mastrobattista

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Related Papers

Annals of the New York Academy of Sciences
Damian Refojo, Florian Holsboer
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
M Intakhab AlamM Akbar
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Mikhail G KoloninWadih Arap
Biochemical and Biophysical Research Communications
H KumagaiM Ohba
© 2022 Meta ULC. All rights reserved